ASTH Long Put Strategy
ASTH (Astrana Health, Inc.), in the Healthcare sector, (Medical - Care Facilities industry), listed on NASDAQ.
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans.
ASTH (Astrana Health, Inc.) trades in the Healthcare sector, specifically Medical - Care Facilities, with a market capitalization of approximately $2.21B, a trailing P/E of 71.93, a beta of 0.94 versus the broader market, a 52-week range of 18.08-44.59, average daily share volume of 519K, a public-listing history dating back to 2009, approximately 2K full-time employees. These structural characteristics shape how ASTH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.94 places ASTH roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 71.93 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a long put on ASTH?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current ASTH snapshot
As of June 30, 2026, spot at $46.03, ATM IV 64.70%, IV rank 43.47%, expected move 18.55%. The long put on ASTH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long put structure on ASTH specifically: ASTH IV at 64.70% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 18.55% (roughly $8.54 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ASTH expiries trade a higher absolute premium for lower per-day decay. Position sizing on ASTH should anchor to the underlying notional of $46.03 per share and to the trader's directional view on ASTH stock.
ASTH long put setup
The ASTH long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ASTH near $46.03, the first option leg uses a $46.03 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ASTH chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ASTH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $46.03 | N/A |
ASTH long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
ASTH long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on ASTH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on ASTH
Long puts on ASTH hedge an existing long ASTH stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ASTH exposure being hedged.
ASTH thesis for this long put
The market-implied 1-standard-deviation range for ASTH extends from approximately $37.49 on the downside to $54.57 on the upside. A ASTH long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long ASTH position with one put per 100 shares held. Current ASTH IV rank near 43.47% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on ASTH should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ASTH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ASTH-specific events.
ASTH long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ASTH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ASTH alongside the broader basket even when ASTH-specific fundamentals are unchanged. Long-premium structures like a long put on ASTH are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ASTH chain quotes before placing a trade.
Frequently asked questions
- What is a long put on ASTH?
- A long put on ASTH is the long put strategy applied to ASTH (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With ASTH stock trading near $46.03, the strikes shown on this page are snapped to the nearest listed ASTH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ASTH long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the ASTH long put priced from the end-of-day chain at a 30-day expiry (ATM IV 64.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ASTH long put?
- The breakeven for the ASTH long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ASTH market-implied 1-standard-deviation expected move is approximately 18.55%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on ASTH?
- Long puts on ASTH hedge an existing long ASTH stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying ASTH exposure being hedged.
- How does current ASTH implied volatility affect this long put?
- ASTH ATM IV is at 64.70% with IV rank near 43.47%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.